Back |
home / stock / lctx / lctx message board
Subject | By | Source | When |
---|---|---|---|
NEWS -- Lineage Cell Therapeutics to Report First | Paulness | investorshub | 05/05/2022 1:14:40 PM |
That is why I load on every big | sweetdwilly | investorshub | 05/05/2022 12:36:32 PM |
Lineage Cell Therapeutics ($LCTX) Received its Third Buy | abracky | investorshub | 05/03/2022 3:51:18 PM |
NEWS -- RG6501 (OpRegen) Phase 1/2a Clinical Results | Paulness | investorshub | 05/03/2022 12:49:25 PM |
Great loading zone approaching here!! Such a solid | sweetdwilly | investorshub | 04/29/2022 10:00:48 AM |
https://www.webcaster4.com/Webcast/Page/2875/45363 | chrismiss_everyday | investorshub | 04/28/2022 4:42:15 AM |
NEWS -- Lineage to Present at B. Riley | Paulness | investorshub | 04/26/2022 1:45:23 PM |
NEWS -- Lineage Announces a Fifth Cell Therapy | Paulness | investorshub | 04/25/2022 1:15:44 PM |
NEWS -- Lineage and Cancer Research UK Announce | Paulness | investorshub | 04/13/2022 1:16:22 PM |
NEWS -- Lineage to Present at the NobleCon18 | Paulness | investorshub | 04/11/2022 12:20:55 PM |
Up on the TASE | chrismiss_everyday | investorshub | 03/28/2022 10:11:26 AM |
https://www.investorsobserver.com/news/stock-update/do-analysts-expect-lineage-c | abracky | investorshub | 03/25/2022 1:43:32 AM |
News, Short Squeeze, Breakout and More Instantly...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that the Company has been added as a member of the broad-market Russell 3000 ® Index, effective after...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that the Company’s CEO, Brian M. Culley, will present at the 2024 BIO International Convention , on Tue...
Persons with Lived Experience Session Expanded to Include Michaela & Kyle Devins Clinical Session Expanded to Include Neuralink Preclinical Session Expanded to Include Axonis, Novoron, Sania & Rewire Medical Lineage Cell Therapeutics, Inc. (NYSE America...